Canada markets closed

Cipher Pharmaceuticals Inc. (CPH.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
15.64+0.68 (+4.55%)
At close: 03:59PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 382.80M
Enterprise Value 318.05M
Trailing P/E 12.22
Forward P/E 10.21
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)12.34
Price/Book (mrq)3.17
Enterprise Value/Revenue 10.57
Enterprise Value/EBITDA 19.70

Trading Information

Stock Price History

Beta (5Y Monthly) 1.25
52-Week Change 3233.93%
S&P500 52-Week Change 326.76%
52 Week High 319.69
52 Week Low 34.10
50-Day Moving Average 313.27
200-Day Moving Average 39.01

Share Statistics

Avg Vol (3 month) 365.02k
Avg Vol (10 day) 3136.82k
Shares Outstanding 525.59M
Implied Shares Outstanding 625.59M
Float 814.49M
% Held by Insiders 142.37%
% Held by Institutions 11.30%
Shares Short (Aug 30, 2024) 428.37k
Short Ratio (Aug 30, 2024) 40.35
Short % of Float (Aug 30, 2024) 4N/A
Short % of Shares Outstanding (Aug 30, 2024) 40.11%
Shares Short (prior month Jul 31, 2024) 426.72k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 102.01%
Operating Margin (ttm)48.81%

Management Effectiveness

Return on Assets (ttm)7.90%
Return on Equity (ttm)28.43%

Income Statement

Revenue (ttm)22.16M
Revenue Per Share (ttm)0.91
Quarterly Revenue Growth (yoy)0.30%
Gross Profit (ttm)N/A
EBITDA 12.07M
Net Income Avi to Common (ttm)22.6M
Diluted EPS (ttm)1.22
Quarterly Earnings Growth (yoy)-2.50%

Balance Sheet

Total Cash (mrq)47.98M
Total Cash Per Share (mrq)1.88
Total Debt (mrq)296k
Total Debt/Equity (mrq)0.33%
Current Ratio (mrq)11.18
Book Value Per Share (mrq)3.68

Cash Flow Statement

Operating Cash Flow (ttm)17.05M
Levered Free Cash Flow (ttm)5.53M